Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT01180504
Eligibility Criteria:
Inclusion Criteria:
* histologically confirmed ovarian cancer or tube cancer or primary peritoneal carcinoma stage FIGO III
* primary optimal debulking surgery
* postoperative gross residual tumor ≤ 1cm ( R0, R1 oder R2 \< 1cm situation)
* adjuvant chemotherapy with platin and taxane
* complete remission after chemotherapy
* Karnofsky performance score \> 60
* patients \>18 years of age
* written informed consent
Exclusion Criteria:
* stage FIGO I or II
* stage III with postoperative gross residual tumor \> 1cm
* stage FIGO IV
* recurrence situation
* delayed wound healing post laparotomy
* leucopenia \<2000/ml before radiotherapy
* thrombocytopenia \<75000/ml before radiotherapy
* clinically active renal, hepatic, cardiac, metabolic, respiratory, coagulation or hematopoietic disease
* status post pelvic or abdominal radiotherapy
* status post other cancer disease in the past 5 years (cervical cancer in situ, basal cell carcinoma, squamous cell carcinoma of the skin are excluded)
* participation in another clinical trial
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01180504
Study Brief:
Protocol Section:
NCT01180504